Cardiac arrest & resuscitation
Airway management with a supraglottic airway device during resuscitation by basic life support providers: a systematic review
Pooled result · Survival to hospital discharge or 30 days (RCTs)Result — go to the resultRR for survival 1.28 95% CI 0.46–3.55Authors' conclusion
A review of current evidence reported no evidence of benefit of SGA compared with BVM use by BLS-trained providers.
Study context
- Population
- Adults with in-hospital or out-of-hospital cardiac arrest managed by Basic Life Support (BLS)-trained providers16 studies (3 RCTs, 13 observational)
- Comparison
- SGA vs bag-valve-mask ventilation by BLS providers
- Outcome
- Survival to hospital discharge or 30 days (RCTs)
- Follow-up
- Hospital discharge or 30 days
Methodological detailsnarrative synthesis (Synthesis without meta-analysis), GRADE, RoB 2.0 and ROBINS-I, Conducted for ILCOR, No studies involved first rescuers or first responders, Meta-analysis not feasible for observational studies due to substantial heterogeneity
- Narrative synthesis (Synthesis without meta-analysis)
- GRADE
- RoB 2.0 and ROBINS-I
- Conducted for ILCOR
- No studies involved first rescuers or first responders
- Meta-analysis not feasible for observational studies due to substantial heterogeneity
Pooled result
As reported in the abstract
RR for survival
1.28
95% CI 0.46–3.55
SGA vs BVM
RR for survival 1.28 (95% CI 0.46–3.55)
Further pooled results
Neurological outcomes, survival at discharge or 30 days, ROSC (observational studies)
- Inconsistent findings and no clear benefit of SGA use
- Very low-certainty evidence
Chest compression fraction
- One RCT suggested a higher chest compression fraction with SGAs
Safety
- Similar emesis rates in RCTs
Original publication
Airway management with a supraglottic airway device during resuscitation by basic life support providers: a systematic review. Resuscitation. Published 26 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →